Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01079780
Title Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pam Cogliano
Indications

colorectal adenocarcinoma

Therapies

Cetuximab + Irinotecan + Ramucirumab

Cetuximab + Irinotecan

Age Groups: adult
Covered Countries USA


No variant requirements are available.